EAPH Financials 07/16/2014 01:06:28
Easton Pharmaceuticals, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses
Research and Development 93 68 6 8
Sales, General and Admin. 249 115 107 49
Non-Recurring Items - - - -
Other - - - -
Operating Income (342) (183) (113) (57)
Income From Continuing Operations
Add'l Income/Expense Items (5) - - -
Earnings Before Interest and Tax (347) (183) (113) (57)
Interest Expense - - - -
Earnings Before Tax (347) (183) (113) (57)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (347) (183) (113) (57)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (347) (183) (113) (57)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (347) (183) (113) (57)
Easton Pharmaceuticals, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses
Research and Development 93 68 6 8
Sales, General and Admin. 249 115 107 49
Non-Recurring Items - - - -
Other - - - -
Operating Income (342) (183) (113) (57)
Income From Continuing Operations
Add'l Income/Expense Items (5) - - -
Earnings Before Interest and Tax (347) (183) (113) (57)
Interest Expense - - - -
Earnings Before Tax (347) (183) (113) (57)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (347) (183) (113) (57)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (347) (183) (113) (57)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (347) (183) (113) (57)
